Medical Oncologist and PhD candidate. Affiliated with Wollongong Hospital, and University of Sydney, 🇦🇺. Views my own.
Sydney, New South Wales
Joined March 2012
- Tweets344
- Following315
- Followers299
- Likes553
Lawrence Kasherman retweeted
🚨Our latest meta-analysis (1st of a 2-part series):
- Pts in comprehensive #cancer centers (CCC) have 23% ↓ overall mortality risk compared to non-CCC
- Mixed results re time to care/ #pallonc
- Look out for our next article on CCCs worldwide
Read here👉tinyurl.com/jhadn4ua
Lawrence Kasherman retweeted
Come and join me as I share reflections on the role of art in the practice of oncology. Excellent panel. Lots of food for thought. Bonus: it will also be a visual feast. #cosa2024
Lawrence Kasherman retweeted
#CancerSurvivorship We are looking forward to share our road map to ensure that AC2 is sustainable, with continued collaborations with our key stakeholders and to identify funding opportunities to continue advancing cancer survivorship care for people with Chinese backgrounds.
Lawrence Kasherman retweeted
After months of planning, we are finally kicking off the AC2 Leadership Forum today! AC2 is a project led by the Caring Futures Institute, Flinders University and our partners across Australia, and countries in the Asia-Pacific region. @AusCGHK
Great to be a part of the AC2 leaders forum in Hong Kong, working towards further collaborations in #CancerSurvivorship care for Chinese speaking populations #survonc @janette_vardy @drcarolynee @chitchadkitchen @rayychan
This forum will drive pivotal conversations about improving cancer survivorship care for people with a Chinese background, through innovation and cross-cultural understanding. Special thanks to HKU for hosting and NFACR for their support! #AC2Forum #CancerSurvivorship
Lawrence Kasherman retweeted
Does belonging to multiple disadvantaged groups = worse health? 🤔 My review shows that it does. This is why clinical trials must address intersectionality if we are to properly tackle health inequalities. #ICTMC2024 #PhD #ClinicalTrials #Intersectionality
Lawrence Kasherman retweeted
Now, lets consider @Erman_Akkus points
Point #1. Patients on the control arm get Atezo-Bev or Sorafenib or Lenva-Pembro when they progress, so this will 'affect' OS
He has to backwards! You WANT them to get the best care, and you have to PROVE treating earlier is better!
Lawrence Kasherman retweeted
Concerned about time toxicity affecting your patients? Contribute to research on this topic by responding to a questionnaire at redcap.slhd.nsw.gov.au/surve…
Lawrence Kasherman retweeted
👀Seeking GP expertise to inform policies and health systems on how to support provision of cancer survivorship in primary care
Developed by GPs, for GPs!
To take part in our national survey please go to qualtrics.flinders.edu.au/jf…
Thank you 🙏 @survonc @PC4TG @COSA_Surviv
Lawrence Kasherman retweeted
Join us this Friday, 🗓️30 August, 📷 ONLINE, 📷#CALD #chinese focused update on Intimacy Changes in Cancer Survivorship. Live translation in Mandarin too! Register using link: trybooking.com/events/landin…
Lawrence Kasherman retweeted
Congratulations @LKasherman winner of the young Onc oral prize! Fantastic research with @janette_vardy @Joanne472 @AshMalalasekera @CindyTa09878114
So great to be flying the flag for qualitative research in survivorship and with CALD populations! #MOGA24 @MOGA_ORG
Lawrence Kasherman retweeted
Groundless complaints can drive doctors away. Here’s why patients need to be held accountable | Ranjana Srivastava theguardian.com/commentisfre…
Lawrence Kasherman retweeted
A joint MASCC-ASCO initiative ➡️ new global standards & practice recs for the consistent provision of high quality #survivorship care to people with advanced or metastatic #cancer & their caregivers 👏
@JCOOP_ASCO @DrNicolasHart @rayychan @CancerCareMASCC
thelimbic.com/oncology/new-g…
Lawrence Kasherman retweeted
🚨Survivorship Care for People affected by Advanced or Metastatic Cancer🚨
💥 MASCC-ASCO Standards / Practice Recommendations now published💥
‼️ Clinical tools online
‼️ 14 languages (coming soon)
Co-published open access:
ascopubs.org/doi/full/10.120… and link.springer.com/article/10…
Lawrence Kasherman retweeted
Multicenter cohort of patients with stage IA p53 abnormal #endometrialcancer without myometrial invasion had 16% risk for recurrent disease with most having distant pattern of recurrence. ijgc.bmj.com/content/34/4/54… @IJGConline @DrAmyJamieson #gyncsm #gynonc
Lawrence Kasherman retweeted
Early Career Clinicians Workshop
“Research is not complete until it’s published and presented” Dr Yeh Chen Lee
“The importance of a mentor “to guide and DRAG you through” Dr Silipa Naiquiso
* Mentors - we all need them, and also need to become them A/Prof Emma Allanson
Lawrence Kasherman retweeted
#Editorial Mirvetuximab soravtansine: an oasis in the desert? 🏜️
@Pinanda76 @LKasherman @AinhoaMada
📌 bit.ly/3Tzg24A
@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4